Rapid Estrogen Receptor-α Activation Improves Ischemic Tolerance in Aged Female Rats through a Novel Protein Kinase Cε-Dependent Mechanism
Authors:
- Amy M. SimpsonASAmy M. Simpson
- Nanette J. TomicekNTNanette J. Tomicek
- Timothy S. LancasterTLTimothy S. Lancaster
- Donna H. KorzickDKDonna H. Korzick
- 1 February 2009
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (2) , 889-896
Abstract
The effects of estrogen deficiency on the loss of cardioprotection with advancing age are complex and poorly understood. A major focus of the current study was to uncover a cardioprotective role for rapid, nongenomic estrogen receptor (ER) signaling in the aged female myocardium. We hypothesized that selective ERalpha activation in aged females would reduce infarct size in part, through reversal of age-associated reductions in mitochondrial protein kinase Cepsilon (PKCepsilon). Hearts isolated from adult (6 month old) and aged (23-24 months old) female F344 rats with ovaries removed (n = 20 per group) were subjected to ischemia/reperfusion (47 min global ischemia). Rats were injected sc with the ERalpha agonist propylpyrazole triol (PPT) or vehicle 45 min before heart isolation (5 microg/kg). Infarct size was greatest in aged vs. adult ovariectomized rats, significantly reduced by PPT, and the protection reversed by prior administration of the ER inhibitor ICI 182,780 (3 mg/kg). Increased ERalpha particulate targeting occurred after PPT in conjunction with reversal of age-related reductions in nuclear PKCepsilon, mitochondrial PKCepsilon and pAkt (P < 0.05). PPT also increased mRNA levels for the PKCepsilon anchoring protein, receptor for activated C kinase2 (RACK2; P < 0.05). Our data suggest, for the first time, that selective ERalpha activation reduces ischemic injury in the aged, estrogen-deficient heart through a mechanism involving nongenomic redistribution of ERalpha and PKCepsilon activation. A novel feed-forward transcriptional mechanism to potentially enhance PKCepsilon-RACK2 interactions was also observed. Collectively, our findings may provide key insight into developing targeted therapeutic interventions in postmenopausal women to reduce ischemia/reperfusion injury, including selective ERalpha mimetics.Keywords
This publication has 25 references indexed in Scilit:
- Signaling by estrogensJournal of Cellular Physiology, 2007
- Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genesMaturitas, 2007
- Treatment with an estrogen receptor-beta-selective agonist is cardioprotectiveJournal of Molecular and Cellular Cardiology, 2007
- Estrogens and SERMs in coronary heart diseaseCurrent Opinion in Pharmacology, 2007
- Post-translational modifications of steroid receptorsBiomedicine & Pharmacotherapy, 2006
- Correspondence regarding Schwend and Gustafsson, “False positives in MALDI-TOF detection of ERβ in mitochondria”Biochemical and Biophysical Research Communications, 2006
- Acute PKCδ inhibition limits ischaemia–reperfusion injury in the aged rat heart: Role of GSK-3βCardiovascular Research, 2006
- Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or betaBiochemical Pharmacology, 2006
- Age- and sex-dependent alterations in protein kinase C (PKC) and extracellular regulated kinase 1/2 (ERK1/2) in rat myocardiumMechanisms of Ageing and Development, 2005
- Acetylation of nuclear receptors in cellular growth and apoptosisBiochemical Pharmacology, 2004